The BCR::ABL1 tyrosine kinase inhibitors ponatinib and nilotinib differentially affect endothelial angiogenesis and signalling
Darya Zibrova(Jena University Hospital), Regine Heller(Jena University Hospital)
Cited by 4
Related Papers
AMPK protects endothelial cells against HSV-1 replication via inhibition of mTORC1 and ACC1
|Microbiology Spectrum|2023|16
Mapping sites of carboxymethyllysine modification on proteins reveals its consequences for proteostasis and cell proliferation
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2
Mapping the endothelial O-GlcNAcome uncovers CCAR1 as a regulator of senescence
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0